Pharma Journalist - Page 96 of 946 -

Fulcrum and Slate Medicines Agree to $245 Million Merger

LEO Pharma Acquires Dersimelagon Rights for Rare Skin Diseases

Sandoz and Henlius Expand Global Biosimilar Collaboration

Creyon Bio and Lilly Partner on RNA-Targeted Oligo Therapy

QIAGEN Expands Digital PCR Portfolio with New Lentivirus Solutions

FDA Approves RINVOQ for Giant Cell Arteritis

Oxford, Boehringer, Cumulus Launch First-Ever Study on Daily Life with Psychiatric Disorders

FDA Approves ZEVASKYN, First Cell-Based Gene Therapy for RDEB

Merck Breaks Ground on $1B Biologics Center in Delaware

Prilenia Partners with Ferrer for Pridopidine in Europe and Beyond

Biohaven Secures Up to $600M Investment from Oberland Capital

Debiopharm and Oncodesign Partner to Boost Radiopharmaceuticals in Preclinical Research

Repertoire Immune and Genentech Partner on T Cell-Targeted Autoimmune Therapies